TY - JOUR T1 - A Survey of Genome Editing Activity for 16 Cpf1 orthologs JF - bioRxiv DO - 10.1101/134015 SP - 134015 AU - Bernd Zetsche AU - Jonathan Strecker AU - Omar O. Abudayyeh AU - Jonathan S. Gootenberg AU - David A. Scott AU - Feng Zhang Y1 - 2017/01/01 UR - http://biorxiv.org/content/early/2017/05/04/134015.abstract N2 - The recently discovered class 2 CRISPR-Cas endonuclease Cpf1 offers several advantages over Cas9, including the ability to process its own array and requirement for just a single RNA guide. These attributes make Cpf1 promising for many genome engineering applications. To further expand the suite of Cpf1 tools available, we tested 16 Cpf1 orthologs for activity in eukaryotic cells. Four of these new enzymes demonstrated targeted activity, one of which, from Moraxella bovoculi AAX11_00205 (Mb3Cpf1), exhibited robust indel formation. We also show that Mb3Cpf1 displays some tolerance for a shortened PAM (TTN versus the canonical Cpf1 PAM TTTV). The addition of these enzymes to the genome editing toolbox will further expand the utility of this powerful technology. ER -